ReviewMolecular diversity2025

Assessment of structural and activity-related contributions of various PIM-1 kinase inhibitors in the treatment of leukemia and prostate cancer.

Anushka Sharma et al.PubMed ↗Publisher ↗

No numbers read from the abstract.